In the BioHarmony Drug Report Database
Methylergonovine
Methergine (methylergonovine) is a small molecule pharmaceutical. Methylergonovine was first approved as Methergine on 1982-01-01. It is used to treat postpartum hemorrhage in the USA. It is known to target 5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 2C, 5-hydroxytryptamine receptor 1F, 5-hydroxytryptamine receptor 2A, 5-hydroxytryptamine receptor 2B, and Soluble cytochrome b562.
Trade Name
|
Methergine |
|---|---|
Common Name
|
methylergonovine |
ChEMBL ID
|
CHEMBL1201356 |
Indication
|
postpartum hemorrhage |
Drug Class
|
Ergot alkaloid derivatives; vinca alkaloids |
Image (chem structure or protein)